Fig. 2From: Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 studyAdherence to SOGUG Guidelines according to hospital category defined as number of cases diagnosed with renal cancer per year (c/y): 1st category hospital (≥ 20 c/y); 2nd category hospital (11–19) c/y and 3rd category hospital (0 to 10 c/y)Back to article page